Apr 18, 2024 13:25
ABVC - ABVC BioPharma, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 2.65 0.04 (1.51%) | --- | 0.0 (0.0%) | -0.02 (-0.74%) | 0.0 (0.0%) | -0.02 (-0.74%) | 0.0 (0.0%) | 0.05 (1.76%) |
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.06
- Diluted EPS:
- -0.06
- Basic P/E:
- -44.8333
- Diluted P/E:
- -44.8333
- RSI(14) 1m:
- 50.0
- VWAP:
- 2.69
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Mar 26, 2024 12:30
Mar 14, 2024 13:30
Feb 08, 2024 14:17
Jan 04, 2024 18:37
Jan 04, 2024 12:59
Jan 03, 2024 17:58
Jan 03, 2024 12:24
Dec 07, 2023 13:30
Nov 21, 2023 18:28